IGC Pharma Balance Sheet
IGC Pharma's total assets for Q4 2026 were $9.19M, a decrease of -5.43% from the previous quarter. IGC total liabilities were $3.06M for the fiscal quarter, a 33.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.